/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
With a market cap of $22.9 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company that provides comprehensive diagnostic, drug development, and laboratory services. Headquartered in Burlington, North Carolina, Labcorp operates a network of laboratories and testing facilities, offering services ranging from routine clinical testing to advanced genomics and clinical trial solutions.
LH is scheduled to report its Q3 earnings on Tuesday, Oct. 28, before the market opens. Ahead of the event, analysts expect the company to report a profit of $4.12 per share, representing a 17.7% increase from $3.50 per share in the same quarter of the previous year. The company has surpassed Wall Street's bottom-line estimates in each of the past four quarters.